List of works - Andrea Annoni

Detection and Characterization of CD8+ Autoreactive Memory Stem T Cells in Patients with Type 1 Diabetes

scientific article published on 5 March 2018

Expression of transforming growth factor-beta1 in thymus of myasthenia gravis patients: correlation with pathological abnormalities.

scientific article

Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy

scientific article

IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus.

scientific article

Immune responses in liver-directed lentiviral gene therapy.

scientific article published on 26 January 2013

Immune responses to lentiviral vectors.

scientific article

Immunization with rat-, but not Torpedo-derived 97-116 peptide of the AChR alpha-subunit induces experimental myasthenia gravis in Lewis rat

scientific article published on 01 September 2003

In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance.

scientific article published in April 2007

Insulin B chain 9-23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3+ Tregs.

scientific article

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens

scientific article published in Nature Communications

Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice

scientific article published on 16 September 2013

Manipulating Immune Tolerance with Micro-RNA Regulated Gene Therapy.

scientific article

Modulation of immune responses in lentiviral vector-mediated gene transfer

scientific article published on 27 April 2018

Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation

scientific article published in Nature Communications

Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates

scientific article published on 01 May 2019

The immune response to lentiviral-delivered transgene is modulated in vivo by transgene-expressing antigen-presenting cells but not by CD4+CD25+ regulatory T cells.

scientific article published on 10 May 2007

List of works by Andrea Annoni

Detection and Characterization of CD8+ Autoreactive Memory Stem T Cells in Patients with Type 1 Diabetes

Expression of transforming growth factor-beta1 in thymus of myasthenia gravis patients: correlation with pathological abnormalities.

Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy

IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus.

Immune responses in liver-directed lentiviral gene therapy.

Immune responses to lentiviral vectors.

Immunization with rat-, but not Torpedo-derived 97-116 peptide of the AChR alpha-subunit induces experimental myasthenia gravis in Lewis rat

In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance.

Insulin B chain 9-23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3+ Tregs.

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens

Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice

Manipulating Immune Tolerance with Micro-RNA Regulated Gene Therapy.

Modulation of immune responses in lentiviral vector-mediated gene transfer

Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation

Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates

The immune response to lentiviral-delivered transgene is modulated in vivo by transgene-expressing antigen-presenting cells but not by CD4+CD25+ regulatory T cells.